SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

111, Inc.
Date: Aug. 6, 2025 · CIK: 0001738906 · Accession: 0000950103-25-009988

Financial Reporting Internal Controls Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-38639

Referenced dates: July 24, 2025

Date
August 6, 2025
Author
By
Form
CORRESP
Company
111, Inc.

Letter

Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 111, Inc. Annual Report on Form 20-F Filed April 29, 2025 File No. 001-38639 Attn: Division of Corporation Finance Office of Trade & Services VIA EDGAR

Re:

Dear Blaise Rhodes and Rufus Decker:

This letter sets forth the responses of 111, Inc. (the " Company ") to the comments (the " Comments ") the Company received from the staff of the Division of Corporation Finance (the " Staff ") of the Securities and Exchange Commission (the " Commission ") in a letter dated July 24, 2025.

For the Staff's convenience, we have included herein the Comments in bold, and the Company's responses are set forth immediately below the Comments.

General Note to the Staff:

The Company respectfully submits in this letter its proposed amendments to the disclosures contained in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2024 filed with the Commission on April 29, 2025 (the " 2024 Annual Report ") (with deletions shown as strike-through and additions underlined). All capitalized terms used but not defined in this letter shall have the meaning ascribed to such terms in the 2024 Form 20-F.

Form 20-F for Fiscal Year Ended December 31, 2024

Consolidated Financial Statements

Reports of Independent Registered Public Accounting Firm, page F-4

1. Please amend your Form 20-F to include an audit report that covers the effects of the retrospective adjustments related to basis of presentation and segment reporting discussed in Note 2(a) and 2(ad) to the financial statements. Refer to PCAOB Staff Questions and Answers on Adjustments to Prior-Period Financial Statements Audited by a Predecessor Auditor, PCAOB AS 3105.54 through .58 and PCAOB AS 3110.06 through .07, as applicable.

Responses: In response to the Staff's comments, the Company has considered the guidance included in PCAOB Staff Questions and Answers on Adjustments to Prior-Period Financial Statements Audited by a Predecessor Auditor, PCAOB AS 3105.54 through .58 and PCAOB AS 3110.06 and confirms that there were no changes made by the company related to the Company's basis of presentation and segment reporting footnote made related to the consolidated financial statements for each of the two years in the period ended December 31, 2023 that were included in the Company's Form 20-F for the year ended December 31, 2024. Specifically, Note 2(a) pertains to the description of the Company's financial condition as of the end of fiscal year 2024 and the following

12 months in compliance with the disclosure requirements of ASC 205-40-50 and no retrospective adjustments were made to the comparable disclosure in the prior year. Additionally, during the year ended December 31, 2024, the Company has evaluated the impact of the adoption of ASC 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. Given the company determined that its only significant segment expense was Segment Cost of Goods sold, which had been disclosed in prior years, and that there were no other segment items, the Company and concluded that the new standard did not have a material impact on the consolidated financial statements for each of the two years in the period ended December 31, 2023. Accordingly, no retrospective adjustments were made to the comparable disclosures in the prior year in Note 2(ad).

If you have further questions or comments regarding, or require further information or clarification of, any of the responses provided in this letter or if the Commission has any questions with respect to 111, Inc.'s Annual Report on Form 20-F, please contact the undersigned or Kevin Zhang (Tel: +852-2533-3384) of Davis Polk & Wardwell LLP.

Sincerely yours,
111, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 August 6, 2025

 Division of Corporation Finance
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549

 Re:

 111, Inc.
Annual Report on Form 20-F
 Filed April 29, 2025
File No. 001-38639

 Attn:
 Division of Corporation Finance
Office of Trade & Services

 VIA EDGAR

 Dear Blaise Rhodes and Rufus Decker:

 This letter sets forth the responses of 111, Inc. (the " Company ")
to the comments (the " Comments ") the Company received from the staff of the Division of Corporation Finance (the " Staff ")
of the Securities and Exchange Commission (the " Commission ") in a letter dated July 24, 2025.

 For the Staff's convenience, we have included herein the Comments
in bold, and the Company's responses are set forth immediately below the Comments.

 General Note to the Staff:

 The Company respectfully submits in this letter its proposed amendments
to the disclosures contained in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2024 filed with
the Commission on April 29, 2025 (the " 2024 Annual Report ") (with deletions shown as strike-through and additions underlined).
All capitalized terms used but not defined in this letter shall have the meaning ascribed to such terms in the 2024 Form 20-F.

 Form 20-F for Fiscal Year Ended December 31, 2024

 Consolidated Financial Statements

 Reports of Independent Registered Public Accounting Firm, page F-4

 1. Please amend your Form 20-F to include an audit report that covers the effects of the retrospective adjustments related to basis
of presentation and segment reporting discussed in Note 2(a) and 2(ad) to the financial statements. Refer to PCAOB Staff Questions and
Answers on Adjustments to Prior-Period Financial Statements Audited by a Predecessor Auditor, PCAOB AS 3105.54 through .58 and PCAOB AS
3110.06 through .07, as applicable.

 Responses: In response to the Staff's comments, the
Company has considered the guidance included in PCAOB Staff Questions and Answers on Adjustments to Prior-Period Financial Statements
Audited by a Predecessor Auditor, PCAOB AS 3105.54 through .58 and PCAOB AS 3110.06 and confirms that there were no changes made by the
company related to the Company's basis of presentation and segment reporting footnote made related to the consolidated financial
statements for each of the two years in the period ended December 31, 2023 that were included in the Company's Form 20-F for the
year ended December 31, 2024. Specifically, Note 2(a) pertains to the description of the Company's financial condition as of the end of
fiscal year 2024 and the following

 12 months in compliance with the disclosure requirements
of ASC 205-40-50 and no retrospective adjustments were made to the comparable disclosure in the prior year. Additionally, during the year
ended December 31, 2024, the Company has evaluated the impact of the adoption of ASC 2023-07 Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures. Given the company determined that its only significant segment expense was Segment Cost
of Goods sold, which had been disclosed in prior years, and that there were no other segment items, the Company and concluded that the
new standard did not have a material impact on the consolidated financial statements for each of the two years in the period ended December
31, 2023. Accordingly, no retrospective adjustments were made to the comparable disclosures in the prior year in Note 2(ad).

 If you have further questions or comments regarding, or require further
information or clarification of, any of the responses provided in this letter or if the Commission has any questions with respect to 111,
Inc.'s Annual Report on Form 20-F, please contact the undersigned or Kevin Zhang (Tel: +852-2533-3384) of Davis Polk & Wardwell
LLP.

 Sincerely yours,

 111, Inc.

 By:

 /s/ Junling
Liu

 Name: Junling Liu

 Title: Chief Executive Officer

 cc:
 Kevin Zhang

 Davis Polk & Wardwell LLP

 Selina Lin (+86 156-0162-0156)
 Grant Thornton Zhitong Certified Public Accountants
 LLP

 Kevin Lin (+86 186-2185-0167)
 Deloitte Touche Tohmatsu Certified Public
Accountants LLP

 2